Vitrolife AB
SWB:VTFN

Watchlist Manager
Vitrolife AB Logo
Vitrolife AB
SWB:VTFN
Watchlist
Price: 12.41 EUR 2.06% Market Closed
Market Cap: 5.4B EUR

Wall Street
Price Targets

VTFN Price Targets Summary
Vitrolife AB

Wall Street analysts forecast VTFN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VTFN is 17.47 EUR with a low forecast of 15.09 EUR and a high forecast of 22.55 EUR.

Lowest
Price Target
15.09 EUR
22% Upside
Average
Price Target
17.47 EUR
41% Upside
Highest
Price Target
22.55 EUR
82% Upside
Vitrolife AB Competitors:
Price Targets
688520
Sinocelltech Group Ltd
19% Upside
PASG
Passage Bio Inc
214% Upside
MRSN
Mersana Therapeutics Inc
75% Upside
AGIO
Agios Pharmaceuticals Inc
44% Upside
GLTO
Galecto Inc
67% Upside
ELDN
Eledon Pharmaceuticals Inc
285% Upside
7774
Japan Tissue Engineering Co Ltd
129% Upside
TLX
Telix Pharmaceuticals Ltd
128% Upside

Revenue
Forecast

Revenue Estimate
Vitrolife AB

For the last 13 years the compound annual growth rate for Vitrolife AB's revenue is 20%. The projected CAGR for the next 4 years is 5%.

20%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Vitrolife AB

For the last 13 years the compound annual growth rate for Vitrolife AB's operating income is 25%. The projected CAGR for the next 3 years is 8%.

25%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Vitrolife AB

For the last 13 years the compound annual growth rate for Vitrolife AB's net income is 24%. The projected CAGR for the next 4 years is 8%.

24%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-21%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VTFN's stock price target?
Price Target
17.47 EUR

According to Wall Street analysts, the average 1-year price target for VTFN is 17.47 EUR with a low forecast of 15.09 EUR and a high forecast of 22.55 EUR.

What is Vitrolife AB's Revenue forecast?
Projected CAGR
5%

For the last 13 years the compound annual growth rate for Vitrolife AB's revenue is 20%. The projected CAGR for the next 4 years is 5%.

What is Vitrolife AB's Operating Income forecast?
Projected CAGR
8%

For the last 13 years the compound annual growth rate for Vitrolife AB's operating income is 25%. The projected CAGR for the next 3 years is 8%.

What is Vitrolife AB's Net Income forecast?
Projected CAGR
8%

For the last 13 years the compound annual growth rate for Vitrolife AB's net income is 24%. The projected CAGR for the next 4 years is 8%.

Back to Top